Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) shares saw an uptick in trading volume on Thursday . 6,515,337 shares were traded during trading, an increase of 56% from the previous session’s volume of 4,163,777 shares.The stock last traded at 1.59 and had previously closed at 1.57. Wall Street Analysts Forecast Growth Several research firms […]
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III bought 25,266 shares of the stock in a transaction dated Monday, January 29th. The stock was acquired at an average price of 0.64 per share, with a total value of 16,170.24. Following the completion of the purchase, the director now owns 211,555 […]
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) insider Markus Puhlmann acquired 280,000 shares of the stock in a transaction on Wednesday, January 24th. The shares were acquired at an average price of 0.50 per share, with a total value of 140,000.00. Following the purchase, the insider now owns 1,375,425 shares in the company, valued […]
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) Director Robert F. Williamson III acquired 22,134 shares of the company’s stock in a transaction on Thursday, January 25th. The stock was purchased at an average cost of 0.49 per share, for a total transaction of 10,845.66. Following the completion of the transaction, the director now owns […]
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) insider Markus Puhlmann bought 280,000 shares of the stock in a transaction dated Wednesday, January 24th. The stock was bought at an average price of 0.50 per share, with a total value of 140,000.00. Following the purchase, the insider now owns 1,375,425 shares of the company’s stock, […]